Relative Intelligence · Medical Devices

How Stryker (SYK) compares with the whole market and its popular alternatives
Built by QuantCommons' quantitative engine, this page is about relative opportunity, not data on SYK alone. It places SYK (Stryker Corporation) against 20+ popular alternatives, its neighboring categories and the entire market of over 10,000 U.S.-listed stocks and ETFs, and surfaces what has done better on consistent outperformance, return for the risk taken, behavior in real market crashes and diversification. The result is a clearer view of where SYK stands in the market, and of the alternatives worth a closer look.
Period covered: SYK's full trading record, from October 1986 through September 2026. All returns include reinvested dividends. Data as of October 20, 2026.
Data as of October 20, 2026. Full tables and charts read best on a larger screen.
On this page12 sections
Key findings
- Right nowOver the past 6 months, SYK fell 9.5% while the S&P 500 rose 9.1%. The slide is SYK's own: it is 23.5% below its high, against 1.3% for the S&P 500. At a glance ↓
- Stock or market?The weakness is SYK's own: it fell 4.3% over the past 3 months while the medical devices ETF IHI (iShares U.S. Medical Devices ETF) rose 7.5%. The S&P 500 rose 3.9%. On the flip side, last month cut against the tape: SYK rose 11.4% while the S&P 500 fell 0.6%.
- Past 1 to 3 yearsSYK has gone against the market, falling 19.2% over the past year while the S&P 500 rose 15.8%. The same gap shows up over 3 years (18.0% against 89.3%). SYK led its medical device peers in 2023, then fell behind JNJ (Johnson & Johnson) and ISRG (Intuitive Surgical) in 2025. By year ↓
- Long termSYK turned $10,000 into $29,700 over the past decade, against $42,100 in the S&P 500. Growth of $10,000 ↓
- In a crashIn the Covid crash, SYK fell 43.8%, against 33.7% for the S&P 500. That was more than JNJ (Johnson & Johnson, 25.4%) but less than ZBH (Zimmer Biomet, 49.6%). SYK fell further than the S&P 500 in three of the last three sell-offs, including the Covid crash (43.8% against 33.7%). Crash tests ↓
- DiversificationSYK is some diversification, but not a hedge: a correlation of 0.52 with the S&P 500 over 5 years and 0.52 with the total US market, more closely than 76% of stocks worth at least $300 million. Over 10 years, SYK's beta versus the S&P 500 was 0.88: in the S&P 500's rising months it gained 82% as much as the index, and in falling months it lost 1.0 times as much. Market capture ↓
- Better options
- Nearby categories and themes
- NVS (Novartis, pharmaceuticals) and COR (Cencora, health care distribution) earned more than SYK with less volatility over the past 5 years. NVS returned 17.1% a year at 20.7% volatility, against 3.2% a year at 25.7%.
- Whole market
- 774 of the 3,633 stocks and funds worth at least $500 million earned more than SYK with less volatility over the past 5 years, among them VTI (Vanguard Morningstar Total Stock Market ETF), VOO (Vanguard S&P 500 ETF) and BRK-B (Berkshire Hathaway).
How much would $10,000 in SYK have grown?
This chart tracks a hypothetical $10,000 investment in SYK over the past 29 years, with dividends reinvested, alongside the same amount in the S&P 500, investments that ended ahead of SYK over the same span and SYK's popular alternatives, among those that traded for the entire period. A second view covers the past 5 years, the period the better options further down the page are judged on. It shows not only where each investment ended up but also how smooth or uneven the path was.
- $10,000 invested in SYK at the end of September 1997 would have grown to $323,233 by September 2026, more than the $132,907 it would have become in SPY, an S&P 500 fund.
- Five of the eight other investments on the chart ended ahead of SYK, and RMD finished highest, at $1,650,038.
Choose a period
From the end of September 1997 to the end of September 2026. The scale is logarithmic, so equal steps up the chart are equal percentage gains. Hover over a fund in the key to pick out its line. 188 of the 1,042 stocks and funds worth at least $500 million that traded the whole period ended ahead of SYK; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- RMD$2M+16,400% total · +19.3% a year
- DGX$784,474+7,745% total · +16.2% a year
- COST$727,732+7,177% total · +15.9% a year
- COR$574,137+5,641% total · +15.0% a year
- FAST$485,606+4,756% total · +14.3% a year
- SYK$323,233+3,132% total · +12.7% a year
- JNJ$189,226+1,792% total · +10.7% a year
- SPY (S&P 500)$132,907+1,229% total · +9.3% a year
- CAH$113,257+1,033% total · +8.7% a year
- THC$32,921+229% total · +4.2% a year
From the end of September 2021 to the end of September 2026. Hover over a fund in the key to pick out its line. 2,324 of the 3,628 stocks and funds worth at least $500 million that traded the whole period ended ahead of SYK; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- CAH$49,682+397% total · +37.8% a year
- THC$38,466+285% total · +30.9% a year
- SPY (S&P 500)$19,000+90.0% total · +13.7% a year
- JNJ$18,849+88.5% total · +13.5% a year
- HCA$18,335+83.3% total · +12.9% a year
- ITGR$14,142+41.4% total · +7.2% a year
- ISRG$12,270+22.7% total · +4.2% a year
- SYK$11,008+10.1% total · +1.9% a year
- STE$10,793+7.9% total · +1.5% a year
- GMED$9,776−2.2% total · −0.5% a year
SYK at a glance
This section summarizes the key facts about the stock, its returns over periods from one to ten years and the risk it has carried, with dividends reinvested throughout. These figures serve as the baseline for every comparison that follows.
- SYK is still 23.5% below its all-time high.
- SYK's deepest decline since it began trading in 1986 was 58.6%, from December 2007 to March 2009. It took about four years from the low to climb back to its old high.
- Over 29 full calendar years, SYK's best was 1998, when it returned 47.9%, and its worst was 2008, when it lost 46.0%. It lost money in five of those years.
The company
- Market value
- $117B
- Industry
- Medical - Devices
- Price history from
- October 1986
Returns
- Past 1 year
- −19.2%total return
- Past 3 years
- +18.0%+5.7% a year
- Past 5 years
- +17.2%+3.2% a year
- Past 10 years
- +197%+11.5% a year
- Best calendar year
- +47.9%1998
- Worst calendar year
- −46.0%2008
- Losing years
- 5 of 29full calendar years
Risk
- Volatility
- 25.7%typical yearly swing, 5 years
- Sharpe ratio
- 0.25return per unit of risk, 5 years
- Worst decline ever
- −58.6%Dec 2007 to Mar 2009
- From its all-time high
- −23.5%below the peak
SYK against the whole market
Where SYK ranks among every stock and fund, and what across the market has done better.
How does SYK rank among all stocks?
This section ranks SYK on return, volatility, risk-adjusted return and worst decline against every stock worth at least $300 million with enough history. Where the comparisons with its popular alternatives show how SYK stacks up against its peers, these rankings show where it stands in the market as a whole.
- SYK's worst decline of the past 10 years ranks in the top 12% of the 2,187 stocks worth at least $300 million, where the top fell the least.
- SYK's 1-year return ranks in the bottom 20% of the 3,287 stocks worth at least $300 million with 1 year of history.
Ranked against U.S.-listed stocks worth at least $300M that have enough history for each measure, so the count changes from row to row; smaller stocks are left out. Lower volatility and smaller declines rank higher.
| Measure | SYK | Rank | Standing |
|---|---|---|---|
| 1-year return | −19.2% | 2,616 of 3,287 | bottom 21% |
| 3-year return | +18.0% | 2,052 of 3,017 | bottom 33% |
| 5-year return | +17.2% | 1,491 of 2,893 | bottom 49% |
| 10-year return | +197% | 874 of 2,202 | top 40% |
| Volatility, 5 years | 25.7% | 384 of 2,893 | top 13% |
| Sharpe ratio, 5 years | 0.25 | 1,689 of 2,893 | bottom 43% |
| Worst decline, past 10 years | −43.8% | 252 of 2,187 | top 12% |
What has beaten SYK on both return and risk?
Each dot is an investment, placed by how much it earned a year over the past 5 years (higher is better) and how much its price swung, its volatility (further left is calmer). SYK sits where the dashed lines cross. Anything in the green box above and to the left earned more than SYK with smaller swings, a better trade-off over this period on both counts. Past results are no promise, but a name in the box is worth a closer look.
- 151 stocks and 623 ETFs worth at least $500 million sit in the green region: each earned more than SYK over the past 5 years with smaller price swings. That is 21% of the 3,633 screened.
- Among those with at least half SYK's swings, DXJ has the best return for its risk: 26.6% a year at 19.1% volatility, 26% less than SYK's 25.7%, and a Sharpe ratio (return above cash per unit of volatility) of 1.34 against 0.25 for SYK.
- Among SYK's popular alternatives, JNJ is in the region. JNJ earned 12.7% a year against 3.2% a year for SYK, at 17.9% volatility, 30% less than SYK's 25.7%.
Annual return is the annualized total return with dividends reinvested, and volatility the annualized swing in daily prices, both over 5 years. Labeled dots are the strongest picks from the table below and the names called out above, colored by how close they sit to SYK; faint dots are 91 more of the 774 in the green region (the strongest, one per fund family). 3,633 stocks and funds worth at least $500 million were screened. Hover over a dot for its figures.
- Popular alternatives
- Same and neighboring categories, and shared themes
- The whole market
- Others in the green region
- 1 with more than 1.6× SYK's volatility is in the table only
Is there a better investment than SYK?
Investments that beat SYK over the past 5 years on return, volatility, drawdowns, consistency, crash losses or fees, from its popular alternatives out to the whole market.
- Among SYK's popular alternatives, JNJ earned more than SYK with less volatility over the past 5 years: 12.7% a year at 17.9% volatility, against 3.2% a year at 25.7%.
- Looking beyond its popular alternatives, NVS (pharmaceuticals) and COR (health care distribution) earned more than SYK with less volatility over the past 5 years. NVS returned 17.1% a year at 20.7% volatility, against 3.2% a year at 25.7%.
- Across the whole market, 774 of the 3,633 stocks and funds worth at least $500 million earned more than SYK with less volatility over the past 5 years, among them VTI, VOO and BRK-B.
How this works
The table below lists investments that beat SYK over the past 5 years on at least one of these measures: a higher annual return with lower volatility, a higher annual return at similar volatility, a similar return with lower volatility, a higher Sharpe ratio with a smaller worst decline, a higher total return in most periods from 3 months to 10 years, or smaller losses in recent market crashes. It checks SYK's popular alternatives first, then the rest of its own and neighboring categories, then every stock and fund worth at least $500 million, and shows the strongest few in each group. The full list of those with a higher return and lower volatility than SYK follows the table.
Annual return is the annualized total return with dividends reinvested. Annual return, volatility and the Sharpe ratio cover 5 years; the worst decline covers the past 10 years. Green marks a better figure than SYK's. "On the frontier" means no other option shown or tested earned more with less volatility. Funds that hold the same thing are shown once. Beyond the popular alternatives, nothing with more than 1.5× SYK's volatility counts as better.
These figures cover the past 5 years. Green marks a better figure than SYK's.
| Investment | Why it is better | Past 5 years | Downside | Long run | Fit | ||||
|---|---|---|---|---|---|---|---|---|---|
| Annual return?higher is better | Volatility?lower is calmer | Sharpe?return per unit of risk | Worst decline?past 10 years | 10Y returntotal | Corr. with SYK?lower diversifies more | Expenseper year | |||
| +3.2% | 25.7% | 0.25 | −43.8% | +197% | 1.00 | — | |||
| +12.7% | 17.1% | 0.79 | −33.7% | +321% | 0.52 | 0.09% | |||
| Popular alternativesbest 6 shownThe investments people most often weigh against SYK. 7 of 20 passed at least one test. | |||||||||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +12.7% | 17.9% | 0.76 | −27.4% | +196% | 0.37 | — | ||
| On the frontierHigher return, similar volatilityHigher return in most periods | +42.1% | 24.7% | 1.55 | −46.1% | +349% | 0.54 | — | ||
| Higher return in most periods | +14.1% | 30.1% | 0.59 | −54.7% | +513% | 0.66 | — | ||
THCTenet Healthcare Corporation · Health Care Facilities | Higher return in most periods | +32.9% | 45.1% | 0.86 | −71.7% | +1,058% | 0.54 | — | |
| Higher return in most periods | +5.2% | 34.6% | 0.32 | −49.9% | +478% | 0.59 | — | ||
GMEDGlobus Medical, Inc. · Medical Devices | Higher return in most periods | +0.3% | 38.6% | 0.20 | −47.9% | +243% | 0.44 | — | |
| Same and neighboring categories, and shared themesbest 6 shownEverything else in Medical Devices and the categories next to it (Health Care Facilities, Pharmaceuticals, Life Sciences Tools, Health Care Distribution), plus SYK's specific themes. 25 of 58 passed at least one test. | |||||||||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +17.1% | 20.7% | 0.87 | −26.8% | +226% | 0.55 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +24.2% | 22.8% | 1.07 | −32.4% | +406% | 0.66 | — | ||
| Higher return, similar volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +38.7% | 25.0% | 1.44 | −38.1% | +586% | 0.41 | — | ||
| Higher return, lower volatilityHigher return in most periods | +26.1% | 23.4% | 1.11 | −45.1% | +603% | 0.24 | — | ||
| Higher return, similar volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +9.5% | 24.5% | 0.49 | −37.6% | +95.1% | 0.36 | — | ||
RMDResMed Inc. · Medical Devices | Higher return in most periodsSmaller losses in recent crashes | −0.3% | 31.8% | 0.15 | −54.0% | +331% | 0.49 | — | |
| The whole marketbest 8 shownEvery other stock and fund worth at least $500 million. 1,522 of 3,556 passed at least one test. | |||||||||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +13.4% | 17.1% | 0.82 | −29.6% | +274% | 0.62 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +14.7% | 16.8% | 0.91 | −37.0% | +204% | 0.46 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +12.1% | 13.7% | 0.90 | −36.8% | +235% | 0.65 | 0.03% | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +17.7% | 18.9% | 0.96 | −26.4% | +213% | 0.24 | 0.40% | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +10.4% | 14.1% | 0.78 | −31.7% | +258% | 0.64 | 0.04% | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +9.7% | 14.3% | 0.72 | −33.4% | +252% | 0.57 | 0.06% | ||
| Higher return, similar volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +15.8% | 24.6% | 0.72 | −30.7% | +576% | 0.38 | — | ||
USHYiShares Broad USD High Yield Corporate Bond ETF · High Yield Bonds | Similar return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +3.6% | 7.4% | 0.52 | −22.4% | — | 0.60 | 0.08% | |
What these numbers mean for SYK
- Annual return
- SYK returned 3.2% a year over the past 5 years with dividends reinvested, against 12.7% a year for the S&P 500. At that pace, $10,000 became about $11,700. Annual return is the steady yearly rate that would produce the same total result, so investments held over the same span compare fairly. Guide: What is performance and return? →
- Volatility
- SYK's volatility over the past 5 years was 25.7%, 1.5 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, SYK's return lands within 25.7% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump. Guide: Understanding and measuring risk (volatility) →
- Sharpe ratio
- SYK's Sharpe ratio over the past 5 years was 0.25, against 0.79 for the S&P 500, so SYK earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings. Guide: Balancing reward with risk (Sharpe ratio) →
- Worst decline
- SYK's worst fall from a peak to a low over the past 10 years was 43.8%, against 33.7% for the S&P 500. Losses and gains are not symmetric: climbing back from a 43.8% fall takes a 77.9% gain. Guide: Market crash risk and tail risk →
- Correlation
- Over the past 5 years, SYK's monthly returns had a correlation of 0.52 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They often move together: some diversification next to an index fund, but not a cushion. In the table, the correlation column measures each option against SYK instead: the lower it is, the more that option would diversify a SYK holding. Guide: Correlation and diversification →
Show all 774 stocks and funds worth at least $500 million that earned more than SYK with less volatility
Out of 3,633 tested over 5 years. The strongest 100 are listed, best first, with funds that hold the same thing listed once.
| # | Investment | Found in | Annual return | Volatility | Sharpe | Worst decline | 10Y return | Corr. with SYK | Expense |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Whole market | +13.4% | 17.1% | 0.82 | −29.6% | +274% | 0.62 | — | |
| 2 | Whole market | +14.7% | 16.8% | 0.91 | −37.0% | +204% | 0.46 | — | |
| 3 | Whole market | +12.1% | 13.7% | 0.90 | −36.8% | +235% | 0.65 | 0.03% | |
| 4 | Whole market | +17.7% | 18.9% | 0.96 | −26.4% | +213% | 0.24 | 0.40% | |
| 5 | Whole market | +10.4% | 14.1% | 0.78 | −31.7% | +258% | 0.64 | 0.04% | |
| 6 | Whole market | +9.7% | 14.3% | 0.72 | −33.4% | +252% | 0.57 | 0.06% | |
| 7 | Whole market | +13.9% | 18.5% | 0.80 | −34.0% | +446% | 0.51 | — | |
| 8 | JAAAJanus Henderson AAA CLO ETF · CLO Bonds | Whole market | +5.1% | 1.7% | 2.98 | −2.6% | — | 0.13 | 0.20% |
| 9 | Whole market | +9.3% | 19.2% | 0.56 | −30.1% | +344% | 0.52 | — | |
| 10 | Whole market | +6.1% | 20.0% | 0.40 | −31.6% | +270% | 0.49 | — | |
| 11 | AEEAmeren Corporation · Electric Utilities | Whole market | +7.9% | 19.4% | 0.49 | −29.1% | +192% | 0.37 | — |
| 12 | Whole market | +11.5% | 17.5% | 0.71 | −35.0% | +302% | 0.52 | 0.03% | |
| 13 | Whole market | +12.8% | 16.9% | 0.80 | −34.0% | +324% | 0.52 | 0.03% | |
| 14 | IOOiShares Global 100 ETF · Global Equity | Whole market | +15.7% | 17.2% | 0.94 | −31.4% | +361% | 0.45 | 0.40% |
| 15 | Popular alternative | +12.7% | 17.9% | 0.76 | −27.4% | +196% | 0.37 | — | |
| 16 | Whole market | +20.8% | 22.6% | 0.96 | −25.7% | +508% | 0.47 | — | |
| 17 | MOATVanEck Morningstar Wide Moat ETF · US Large-Cap Equity | Whole market | +9.1% | 18.4% | 0.57 | −33.3% | +276% | 0.59 | 0.46% |
| 18 | IWXiShares Russell Top 200 Value ETF · Broad Market | Whole market | +12.7% | 13.8% | 0.94 | −35.8% | +221% | 0.62 | 0.20% |
| 19 | Whole market | +12.8% | 22.9% | 0.64 | −36.4% | +429% | 0.58 | — | |
| 20 | LVHIFranklin International Low Volatility High Dividend Index ETF · International Equity | Whole market | +17.0% | 11.1% | 1.48 | −32.4% | +194% | 0.50 | 0.40% |
| 21 | BALTInnovator Defined Wealth Shield ETF · Crypto | Whole market | +6.3% | 3.3% | 1.85 | −4.9% | — | 0.47 | 0.69% |
| 22 | Whole market | +17.4% | 22.9% | 0.82 | −31.4% | +685% | 0.41 | — | |
| 23 | Whole market | +8.2% | 16.4% | 0.57 | −36.0% | +140% | 0.47 | 0.05% | |
| 24 | Whole market | +14.5% | 23.0% | 0.71 | −35.1% | +553% | 0.32 | 0.18% | |
| 25 | FLRTPacer Aristotle Pacific Floating Rate High Income ETF · Financials | Whole market | +6.0% | 2.3% | 2.55 | −21.0% | +58.0% | 0.25 | 0.60% |
| 26 | Whole market | +9.3% | 16.9% | 0.61 | −35.8% | +153% | 0.54 | 0.03% | |
| 27 | QUSState Street SPDR MSCI USA StrategicFactors ETF · Broad Market | Whole market | +11.1% | 14.2% | 0.81 | −33.8% | +273% | 0.63 | 0.15% |
| 28 | Whole market | +11.5% | 20.9% | 0.63 | −32.6% | +394% | 0.54 | — | |
| 29 | EQLALPS Equal Sector Weight ETF · Broad Market | Whole market | +13.5% | 14.5% | 0.94 | −34.2% | +387% | 0.65 | 0.19% |
| 30 | QDEFNorthern Trust Quality Dividend Defensive ETF · Dividend & Income | Whole market | +12.7% | 13.7% | 0.94 | −35.7% | +228% | 0.60 | 0.40% |
| 31 | Whole market | +7.1% | 22.9% | 0.42 | −38.7% | +295% | 0.40 | — | |
| 32 | Whole market | +11.1% | 24.2% | 0.56 | −36.7% | +204% | 0.26 | — | |
| 33 | Whole market | +10.3% | 16.2% | 0.69 | −34.2% | +223% | 0.53 | 0.06% | |
| 34 | Whole market | +11.3% | 18.8% | 0.67 | −38.4% | +170% | 0.32 | — | |
| 35 | Whole market | +6.8% | 19.4% | 0.44 | −38.7% | +122% | 0.21 | 0.09% | |
| 36 | Whole market | +5.2% | 17.5% | 0.38 | −36.4% | +102% | 0.20 | 0.06% | |
| 37 | Whole market | +5.2% | 8.9% | 0.61 | −25.4% | +37.8% | 0.34 | — | |
| 38 | Whole market | +11.2% | 20.8% | 0.62 | −37.4% | +319% | 0.29 | — | |
| 39 | Whole market | +5.5% | 21.5% | 0.36 | −30.1% | +89.8% | 0.50 | — | |
| 40 | PJULInnovator U.S. Equity Power Buffer ETF · Broad Market | Whole market | +10.5% | 8.6% | 1.20 | −18.2% | — | 0.51 | 0.79% |
| 41 | Whole market | +14.8% | 23.6% | 0.71 | −32.8% | +625% | 0.60 | — | |
| 42 | FJANFT Vest U.S. Equity Buffer ETF - January · Multi-Asset | Whole market | +11.1% | 10.5% | 1.05 | −13.6% | — | 0.48 | 0.85% |
| 43 | Whole market | +7.5% | 18.0% | 0.50 | −37.4% | +132% | 0.37 | — | |
| 44 | Whole market | +12.4% | 20.2% | 0.68 | −32.9% | +185% | 0.34 | — | |
| 45 | Whole market | +13.1% | 22.4% | 0.67 | −34.5% | +451% | 0.39 | 0.04% | |
| 46 | Whole market | +14.7% | 17.5% | 0.87 | −34.7% | — | 0.50 | 0.26% | |
| 47 | Whole market | +7.2% | 19.2% | 0.46 | −29.0% | +68.8% | 0.49 | — | |
| 48 | Whole market | +6.7% | 21.4% | 0.41 | −37.9% | +208% | 0.65 | — | |
| 49 | Whole market | +7.5% | 11.0% | 0.71 | −13.7% | — | 0.71 | 0.35% | |
| 50 | Whole market | +12.0% | 18.8% | 0.70 | −30.9% | +114% | 0.26 | — | |
| 51 | Whole market | +8.4% | 15.3% | 0.60 | −28.4% | +202% | 0.62 | 0.08% | |
| 52 | CHTChunghwa Telecom Co., Ltd. · Integrated Telecommunications | Whole market | +7.7% | 13.3% | 0.63 | −23.8% | +101% | 0.18 | — |
| 53 | SPMOInvesco S&P 500 Momentum ETF · US Momentum Equity | Whole market | +18.7% | 20.8% | 0.93 | −30.9% | +499% | 0.44 | 0.13% |
| 54 | Whole market | +15.7% | 20.4% | 0.82 | −42.6% | +248% | 0.44 | — | |
| 55 | DFIVDimensional - International Value ETF · International Equity | Whole market | +14.8% | 16.4% | 0.93 | −25.4% | — | 0.52 | 0.27% |
| 56 | Whole market | +6.5% | 20.9% | 0.41 | −34.4% | +156% | 0.24 | — | |
| 57 | AVLVAvantis U.S. Large Cap Value ETF · US Large-Cap Value | Whole market | +14.0% | 16.9% | 0.86 | −19.5% | — | 0.57 | 0.15% |
| 58 | Whole market | +22.4% | 22.3% | 1.02 | −46.3% | +347% | 0.53 | — | |
| 59 | HYGHiShares Interest Rate Hedged High Yield Bond ETF · Bonds | Whole market | +6.6% | 7.1% | 0.94 | −23.9% | +74.5% | 0.59 | 1.12% |
| 60 | HDViShares Core High Dividend ETF · US Dividend Equity | Whole market | +12.9% | 13.0% | 1.00 | −37.0% | +172% | 0.60 | 0.08% |
| 61 | WECWEC Energy Group, Inc. · Electric Utilities | Whole market | +7.2% | 19.0% | 0.46 | −32.3% | +159% | 0.35 | — |
| 62 | DFATDimensional - US Targeted Value ETF · US Small-Cap Equity | Whole market | +9.6% | 21.0% | 0.54 | −26.1% | — | 0.51 | 0.33% |
| 63 | DGXQuest Diagnostics Incorporated · Medical Diagnostics | Whole market | +12.3% | 22.5% | 0.63 | −36.6% | +243% | 0.54 | — |
| 64 | FTSFortis Inc. · Electric Utilities | Whole market | +8.4% | 16.4% | 0.58 | −34.3% | +154% | 0.45 | — |
| 65 | Same or nearby category | +17.1% | 20.7% | 0.87 | −26.8% | +226% | 0.55 | — | |
| 66 | USMViShares MSCI USA Min Vol Factor ETF · US Low-Volatility Equity | Whole market | +7.6% | 12.3% | 0.66 | −33.1% | +176% | 0.68 | 0.15% |
| 67 | SPHQInvesco S&P 500 Quality ETF · US Quality Equity | Whole market | +12.0% | 16.7% | 0.76 | −31.6% | +300% | 0.60 | 0.20% |
| 68 | COWZPacer US Cash Cows 100 ETF · US Large-Cap Value | Whole market | +11.4% | 17.7% | 0.70 | −38.7% | — | 0.56 | 0.49% |
| 69 | EWJiShares MSCI Japan ETF · International Equity | Whole market | +9.2% | 18.8% | 0.57 | −33.1% | +132% | 0.47 | 0.49% |
| 70 | WTWWillis Towers Watson Public Limited Company · Insurance | Whole market | +6.9% | 23.9% | 0.40 | −32.9% | +187% | 0.49 | — |
| 71 | XLUState Street Utilities Select Sector SPDR ETF · Utilities Equity | Whole market | +7.8% | 17.4% | 0.52 | −36.0% | +138% | 0.44 | 0.08% |
| 72 | SDYState Street SPDR S&P Dividend ETF · US Dividend Equity | Whole market | +7.6% | 14.0% | 0.59 | −36.7% | +157% | 0.63 | 0.35% |
| 73 | BUFRFT Vest Laddered Buffer ETF · Buffered Equity | Whole market | +9.9% | 10.5% | 0.96 | −13.7% | — | 0.52 | 0.10% |
| 74 | Whole market | +17.3% | 18.2% | 0.97 | −40.0% | +352% | 0.34 | — | |
| 75 | RWLInvesco S&P 500 Revenue ETF · US Large-Cap Equity | Whole market | +13.7% | 14.4% | 0.97 | −36.1% | +287% | 0.63 | 0.39% |
| 76 | EVRGEvergy, Inc. · Electric Utilities | Whole market | +9.5% | 18.9% | 0.57 | −38.8% | +109% | 0.38 | — |
| 77 | CHDChurch & Dwight Co., Inc. · Household & Personal Products | Whole market | +6.1% | 21.1% | 0.39 | −31.7% | +154% | 0.52 | — |
| 78 | Same or nearby category | +24.2% | 22.8% | 1.07 | −32.4% | +406% | 0.66 | — | |
| 79 | DBEFXtrackers MSCI EAFE Hedged Equity ETF · International Equity | Whole market | +13.1% | 13.8% | 0.96 | −32.5% | +206% | 0.57 | 0.35% |
| 80 | BKLNInvesco Senior Loan ETF · Bank Loans | Whole market | +5.4% | 4.5% | 1.19 | −24.1% | +50.7% | 0.41 | 0.67% |
| 81 | Whole market | +19.2% | 22.4% | 0.90 | −42.0% | +311% | 0.27 | — | |
| 82 | JQUAJPMorgan U.S. Quality Factor ETF · US Quality Equity | Whole market | +13.6% | 15.7% | 0.89 | −32.9% | — | 0.58 | 0.12% |
| 83 | DIVOAmplify CWP Enhanced Dividend Income ETF · Equity Income | Whole market | +11.1% | 11.9% | 0.95 | −30.0% | — | 0.67 | 0.56% |
| 84 | SRLNState Street Blackstone Senior Loan ETF · Bank Loans | Whole market | +4.7% | 3.9% | 1.18 | −22.3% | +54.2% | 0.33 | 0.70% |
| 85 | LNTAlliant Energy Corporation · Electric Utilities | Whole market | +7.3% | 19.8% | 0.46 | −33.5% | +150% | 0.37 | — |
| 86 | XLPState Street Consumer Staples Select Sector SPDR ETF · Consumer Staples | Whole market | +7.2% | 13.8% | 0.57 | −24.5% | +121% | 0.64 | 0.08% |
| 87 | Whole market | +4.4% | 20.9% | 0.31 | −35.8% | +245% | 0.56 | — | |
| 88 | FTSLFirst Trust Senior Loan Fund · Bonds | Whole market | +5.0% | 3.4% | 1.49 | −22.7% | +52.1% | 0.33 | 0.70% |
| 89 | SHYGiShares 0-5 Year High Yield Corporate Bond ETF · High Yield Bonds | Whole market | +4.5% | 5.8% | 0.79 | −19.3% | +56.4% | 0.61 | 0.30% |
| 90 | ACTEnact Holdings Inc. · Insurance | Whole market | +20.5% | 24.3% | 0.89 | −20.2% | — | 0.33 | — |
| 91 | QYLDGlobal X - Nasdaq 100 Covered Call ETF · Equity Income | Whole market | +8.4% | 15.0% | 0.62 | −24.7% | +156% | 0.35 | 0.60% |
| 92 | BBEUJPMorgan BetaBuilders Europe ETF · International Equity | Whole market | +8.9% | 17.5% | 0.57 | −36.3% | — | 0.57 | 0.09% |
| 93 | FLTWFranklin FTSE Taiwan ETF · Technology | Whole market | +21.8% | 24.3% | 0.94 | −38.0% | — | 0.11 | 0.19% |
| 94 | DBMFiMGP DBi Managed Futures Strategy ETF · Alternatives | Whole market | +9.8% | 12.4% | 0.82 | −20.4% | — | -0.14 | 0.85% |
| 95 | USMCPrincipal U.S. Mega-Cap ETF · Broad Market | Whole market | +14.1% | 16.4% | 0.89 | −30.0% | — | 0.49 | 0.12% |
| 96 | GCOWPacer Global Cash Cows Dividend ETF · International | Whole market | +14.1% | 13.6% | 1.04 | −37.6% | +168% | 0.50 | 0.60% |
| 97 | IDAIDACORP, Inc. · Electric Utilities | Whole market | +8.8% | 19.2% | 0.54 | −34.3% | +141% | 0.37 | — |
| 98 | FTCSFirst Trust Capital Strength ETF · US Quality Equity | Whole market | +6.2% | 13.2% | 0.52 | −31.9% | +188% | 0.71 | 0.53% |
| 99 | TDIVFirst Trust NASDAQ Technology Dividend Index Fund · Technology Equity | Whole market | +16.2% | 21.3% | 0.81 | −32.0% | +388% | 0.35 | 0.50% |
| 100 | Whole market | +23.5% | 18.8% | 1.22 | −75.2% | +350% | 0.54 | — |
SYK against its popular alternatives
The investments people most often weigh against SYK, compared period by period and year by year.
How do SYK's risk and return compare with its alternatives?
This map plots each investment's annual return over the past 5 years against its volatility, the size of its typical price swings. Investments toward the upper left earned more for a smoother ride, and those toward the lower right earned less for a rougher one. The dashed lines cross at SYK, which divides the map into what did better or worse on each measure.
- Only CAH and JNJ were both more rewarding and calmer than SYK over the past 5 years, earning a higher annual return with lower volatility.
- 11 of the 20 popular alternatives earned less than SYK over the past 5 years while swinging more, the weaker corner of the map.
- Over the past 5 years, SYK returned 3.2% a year, less than the S&P 500's 12.7%, with higher volatility (25.7% against 17.1%).
Green points earned more than SYK with less volatility; red points earned less with more. Hover over a point for its figures. Total returns with dividends reinvested, annualized.
All figures
| Investment | Annual return | Volatility |
|---|---|---|
| CAH Cardinal Health, Inc. | +42.1% | 24.7% |
| THC Tenet Healthcare Corporation | +32.9% | 45.1% |
| HCA HCA Healthcare, Inc. | +14.1% | 30.1% |
| JNJ Johnson & Johnson | +12.7% | 17.9% |
| SPY S&P 500State Street SPDR S&P 500 ETF | +12.7% | 17.1% |
| ITGR Integer Holdings Corporation | +6.9% | 35.3% |
| ISRG Intuitive Surgical, Inc. | +5.2% | 34.6% |
| SYK This pageStryker Corporation | +3.2% | 25.7% |
| BDX Becton, Dickinson and Company | +2.3% | 24.1% |
| STE STERIS plc | +0.9% | 26.2% |
| BSX Boston Scientific Corporation | +0.5% | 26.6% |
| GMED Globus Medical, Inc. | +0.3% | 38.6% |
| SNN Smith & Nephew plc | −1.2% | 27.5% |
| ABT Abbott Laboratories | −1.7% | 23.1% |
| MDT Medtronic Plc | −1.8% | 22.5% |
| ATEC Alphatec Holdings, Inc. | −2.4% | 63.5% |
| EW Edwards Lifesciences Corporation | −5.3% | 32.7% |
| ZBH Zimmer Biomet Holdings, Inc. | −7.2% | 27.2% |
| CNMD CONMED Corporation | −19.4% | 41.3% |
| INSP Inspire Medical Systems, Inc. | −22.3% | 61.0% |
| OFIX Orthofix Medical Inc. | −23.1% | 46.4% |
| ENOV Enovis Corporation | −25.1% | 43.0% |
Has SYK consistently beaten its popular alternatives?
This section compares SYK with the investments people most often weigh against it, checking each one over eight periods from one month to ten years. Counting how often an alternative earned more than SYK helps separate lasting outperformance from a single strong stretch.
- Seven of the 21 popular alternatives, led by CAH, THC and ITGR, outperformed SYK in at least 3 of 5 short-term and 2 of 3 long-term timeframes.
- CAH, THC and ITGR outperformed SYK in every long-term period and in all but one short-term period, the most consistent record in the group.
- JNJ earned more for the risk it took than SYK (a higher Sharpe ratio) and fell less in its worst decline of the past 10 years.
A green cell means the alternative earned more than SYK over that period. "Qualified" marks those that did so in at least 3 of 5 short-term periods and 2 of 3 long-term periods.
| Investment | Periods outperformed | Short term | Long term | Risk · 5 years | Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Volatilitylower is calmer | Sharpehigher is better | Worst declinepast 10 years | Expense | Assets | Overlapsame sectors | ||
| SYK Stryker Corporation (this page) | — | +11.4% | −4.3% | −9.5% | −11.8% | −19.2% | +18.0% | +17.2% | +197% | 25.7% | 0.25 | −43.8% | — | $117B | — |
| CAH QualifiedCardinal Health, Inc. | 5/5 short3/3 longAll-weather | +14.3% | +14.3% | +22.5% | +26.1% | +65.3% | +191% | +479% | +349% | 24.7% | 1.55 | −46.1% | — | $60B | — |
| THC QualifiedTenet Healthcare Corporation | 4/5 short3/3 longAll-weather | +4.3% | +40.1% | +42.4% | +36.5% | +34.7% | +399% | +315% | +1,058% | 45.1% | 0.86 | −71.7% | — | $22B | — |
| ITGR QualifiedInteger Holdings Corporation | 4/5 short3/3 longAll-weather | +0.3% | +31.9% | +41.9% | +65.0% | +18.0% | +76.0% | +39.4% | +557% | 35.3% | 0.37 | −56.1% | — | $4.3B | — |
| HCA QualifiedHCA Healthcare, Inc. | 4/5 short3/3 longAll-weather | +9.3% | +26.0% | −2.2% | −0.5% | +8.3% | +97.6% | +93.6% | +513% | 30.1% | 0.59 | −54.7% | — | $101B | — |
| ISRG QualifiedIntuitive Surgical, Inc. | 3/5 short3/3 long | +9.0% | +24.0% | −5.9% | −22.1% | −4.5% | +64.1% | +28.9% | +478% | 34.6% | 0.32 | −49.9% | — | $155B | — |
| JNJ QualifiedJohnson & Johnson | 4/5 short2/3 long | −3.8% | +4.8% | +13.6% | +27.1% | +36.9% | +84.6% | +82.1% | +196% | 17.9% | 0.76 | −27.4% | — | $625B | — |
| GMED QualifiedGlobus Medical, Inc. | 3/5 short2/3 long | +6.3% | +3.9% | −18.4% | −9.6% | +28.2% | +53.9% | +1.3% | +243% | 38.6% | 0.20 | −47.9% | — | $11B | — |
| STE Medical - SpecialtiesSTERIS plc | 4/5 short1/3 long | +8.8% | +5.3% | +0.1% | −9.2% | −6.0% | +7.0% | +4.5% | +262% | 26.2% | 0.17 | −36.2% | — | $22B | — |
| EW Medical - DevicesEdwards Lifesciences Corporation | 4/5 short1/3 long | −0.1% | +3.9% | +8.4% | +3.5% | +17.3% | +27.1% | −23.6% | +125% | 32.7% | 0.01 | −54.3% | — | $51B | — |
| MDT Medical - DevicesMedtronic Plc | 4/5 short1/3 long | +4.0% | +14.5% | +13.3% | +1.0% | +1.9% | +43.6% | −8.8% | +46.7% | 22.5% | 0.03 | −45.1% | — | $121B | — |
| SNN Medical - DevicesSmith & Nephew plc | 3/5 short1/3 long | +7.2% | −2.5% | −13.3% | −8.4% | −17.1% | +41.6% | −5.9% | +20.5% | 27.5% | 0.09 | −55.1% | — | $12B | — |
| ABT Medical - DevicesAbbott Laboratories | 2/5 short1/3 long | +0.3% | +1.6% | +8.4% | −15.3% | −18.7% | +13.0% | −8.0% | +204% | 23.1% | 0.04 | −39.6% | — | $178B | — |
| BDX Medical - Instruments & SuppliesBecton, Dickinson and Company | 4/5 short0/3 long | +7.2% | +26.2% | +23.7% | +28.9% | +32.3% | +1.6% | +12.2% | +71.4% | 24.1% | 0.22 | −39.9% | — | $53B | — |
| CNMD Medical - DevicesCONMED Corporation | 4/5 short0/3 long | +6.5% | +9.5% | +19.9% | +17.4% | −0.4% | −47.3% | −65.9% | +30.2% | 41.3% | -0.32 | −78.8% | — | $1.4B | — |
| ZBH Medical - DevicesZimmer Biomet Holdings, Inc. | 4/5 short0/3 long | +2.1% | +7.3% | +1.1% | +7.5% | −5.6% | −5.5% | −31.1% | −16.1% | 27.2% | -0.14 | −52.1% | — | $18B | — |
| GEHC Medical - DevicesGE HealthCare Technologies Inc. | 3/5 short0/3 long | +8.4% | +11.8% | −5.2% | −15.1% | −6.8% | +10.1% | — | — | — | — | −37.4% | — | $32B | — |
| INSP Medical - DevicesInspire Medical Systems, Inc. | 3/5 short0/3 long | −5.8% | +33.9% | +25.2% | −22.7% | −11.7% | −54.3% | −71.6% | — | 61.0% | -0.10 | −87.7% | — | $2.1B | — |
| ATEC Medical - DevicesAlphatec Holdings, Inc. | 2/5 short0/3 long | +6.8% | +31.3% | −6.0% | −47.7% | −29.9% | −11.3% | −11.4% | +81.6% | 63.5% | 0.28 | −81.8% | — | $1.7B | — |
| BSX Medical - DevicesBoston Scientific Corporation | 1/5 short0/3 long | +4.3% | +4.1% | −25.3% | −51.9% | −54.7% | −8.9% | +2.5% | +98.1% | 26.6% | 0.15 | −61.6% | — | $66B | — |
| ENOV Medical - DevicesEnovis Corporation | 1/5 short0/3 long | +14.7% | −22.9% | −21.2% | −22.0% | −36.2% | −53.5% | −76.4% | −59.0% | 43.0% | -0.46 | −80.9% | — | $1.2B | — |
| OFIX Medical - DevicesOrthofix Medical Inc. | 0/5 short0/3 long | +10.1% | −14.8% | −22.1% | −33.6% | −36.9% | −10.4% | −73.1% | −75.3% | 46.4% | -0.33 | −87.2% | — | $398M | — |
How did SYK do year by year?
This table shows each investment's total return in every full calendar year since 1997, along with where SYK ranked among its popular alternatives each year. Annual results reveal how consistently each one kept pace with SYK and how far its good and bad years diverged, detail that multiyear averages tend to smooth over.
- SYK finished ahead of the S&P 500 in 15 of its 29 full calendar years, and behind it in each of the last three.
- Ranked against its popular alternatives each year, SYK finished in the top quarter in seven of 29 years and in the bottom quarter in no. In 2025, it ranked 15 of 22.
- Among its popular alternatives, ISRG came out ahead of SYK most often, in 16 of the 25 years both traded.
Newest year first. Green marks a year in which the fund came out ahead of SYK; gray means the two finished within a fraction of a point. The rank row places SYK among the alternatives that traded the full year; dark green is the top quarter and red the bottom quarter.
| Investment | Years ahead of SYK | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SYK This pageStryker Corporation | — | −1.5% | +21.3% | +23.8% | −7.4% | +10.2% | +18.2% | +35.3% | +2.4% | +30.8% | +30.7% | 0.0% | +27.4% | +39.3% | +12.1% | −6.1% | +7.9% | +26.7% | −46.0% | +36.2% | +24.5% | −7.7% | +13.7% | +26.8% | +15.2% | +15.6% | +45.6% | +26.6% | +47.9% | +25.0% |
| Rank among alternatives | Top quarter in 7 of 29 | 15 of 22 | 7 of 22 | 8 of 22 | 10 of 21 | 13 of 21 | 6 of 21 | 10 of 21 | 14 of 20 | 8 of 20 | 2 of 20 | 13 of 20 | 9 of 20 | 12 of 20 | 9 of 19 | 10 of 18 | 9 of 18 | 9 of 18 | 13 of 17 | 2 of 17 | 3 of 16 | 10 of 16 | 8 of 16 | 8 of 16 | 4 of 16 | 10 of 14 | 5 of 11 | 1 of 10 | 3 of 10 | 8 of 10 |
| SPY S&P 500State Street SPDR S&P 500 ETF | 12 of 29 | +17.7% | +24.9% | +26.2% | −18.2% | +28.7% | +18.3% | +31.2% | −4.6% | +21.7% | +12.0% | +1.2% | +13.5% | +32.3% | +16.0% | +1.9% | +15.1% | +26.4% | −36.8% | +5.1% | +15.9% | +4.8% | +10.7% | +28.2% | −21.6% | −11.7% | −9.8% | +20.4% | +28.7% | +33.5% |
| CAH Cardinal Health, Inc. | 12 of 29 | +76.3% | +19.0% | +34.1% | +54.1% | −0.4% | +10.1% | +18.0% | −24.5% | −12.7% | −17.5% | +12.6% | +23.0% | +66.0% | +3.8% | +8.1% | +21.4% | −4.4% | −39.6% | −9.8% | −5.8% | +18.7% | −4.7% | +3.5% | −8.3% | −2.5% | +108% | −36.8% | +51.7% | +29.1% |
| THC Tenet Healthcare Corporation | 12 of 29 | +57.4% | +67.0% | +54.9% | −40.3% | +105% | +5.0% | +122% | +13.1% | +2.2% | −51.0% | −40.2% | +20.3% | +29.7% | +58.2% | −23.3% | +24.1% | +369% | −77.4% | −27.1% | −9.0% | −30.2% | −31.6% | −2.1% | −58.1% | +32.1% | +89.2% | −10.5% | −20.8% | +51.4% |
| ITGR Integer Holdings Corporation | 11 of 25 | −40.8% | +33.8% | +44.7% | −20.0% | +5.4% | +0.9% | +5.5% | +68.3% | +53.8% | −43.9% | +6.5% | +11.4% | +90.4% | +5.2% | −8.5% | +25.6% | −27.3% | +32.4% | −25.7% | +3.5% | +16.0% | −47.0% | +44.8% | −19.1% | +27.8% | — | — | — | — |
| HCA HCA Healthcare, Inc. | 7 of 14 | +56.7% | +11.8% | +13.8% | −5.6% | +57.6% | +11.6% | +20.2% | +43.4% | +18.7% | +9.4% | −7.8% | +53.8% | +58.1% | +70.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ISRG Intuitive Surgical, Inc. | 16 of 25 | +8.5% | +54.7% | +27.1% | −26.2% | +31.8% | +38.4% | +23.4% | +31.2% | +72.7% | +16.1% | +3.3% | +37.7% | −21.7% | +5.9% | +79.6% | −15.0% | +139% | −60.7% | +237% | −18.2% | +193% | +134% | +38.7% | −38.6% | +18.0% | — | — | — | — |
| JNJ Johnson & Johnson | 9 of 29 | +47.5% | −4.8% | −8.6% | +6.0% | +11.4% | +10.8% | +16.2% | −5.1% | +24.4% | +15.3% | +1.2% | +17.3% | +34.6% | +10.8% | +9.9% | −0.6% | +11.3% | −7.7% | +3.6% | +12.4% | −3.4% | +25.2% | −2.0% | −7.9% | +14.0% | +14.2% | +12.5% | +29.0% | +34.3% |
| GMED Globus Medical, Inc. | 7 of 13 | +5.6% | +55.2% | −28.2% | +2.9% | +10.7% | +10.8% | +36.0% | +5.3% | +65.7% | −10.8% | +17.0% | +17.8% | +92.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STE STERIS plc | 14 of 29 | +24.6% | −5.6% | +20.2% | −23.4% | +29.5% | +25.5% | +44.1% | +23.6% | +31.7% | −9.1% | +17.9% | +37.2% | +40.9% | +19.2% | −16.5% | +32.5% | +26.3% | −16.4% | +15.4% | +1.4% | +6.0% | +4.9% | −6.8% | +32.8% | +13.2% | +57.4% | −63.9% | +17.8% | +10.9% |
| EW Edwards Lifesciences Corporation | 13 of 25 | +15.2% | −2.9% | +2.2% | −42.4% | +42.0% | +17.3% | +52.3% | +35.9% | +20.3% | +18.6% | +24.0% | +93.7% | −27.1% | +27.6% | −12.6% | +86.1% | +58.1% | +19.6% | −2.3% | +13.0% | +0.9% | +37.0% | +18.4% | −7.8% | +55.4% | — | — | — | — |
| MDT Medtronic Plc | 10 of 29 | +24.0% | +0.3% | +9.6% | −22.6% | −9.8% | +5.7% | +27.3% | +15.2% | +15.3% | −5.4% | +8.6% | +28.1% | +42.8% | +10.6% | +5.8% | −13.8% | +42.6% | −36.3% | −5.2% | −6.3% | +16.8% | +2.7% | +7.3% | −10.3% | −14.8% | +66.4% | −1.5% | +42.1% | +55.3% |
| SNN Smith & Nephew plc | 9 of 26 | +36.8% | −7.3% | +4.4% | −20.2% | −16.2% | −10.4% | +30.8% | +8.9% | +18.5% | −13.9% | −1.4% | +31.8% | +32.5% | +17.5% | −6.9% | +4.1% | +61.7% | −43.2% | +10.7% | +14.1% | −9.4% | +24.6% | +38.3% | +2.4% | +33.7% | +40.4% | — | — | — |
| ABT Abbott Laboratories | 13 of 29 | +12.9% | +4.8% | +2.3% | −20.7% | +30.5% | +28.1% | +22.1% | +29.1% | +52.0% | −12.3% | +1.9% | +20.1% | +24.3% | +20.3% | +21.8% | −8.3% | +4.6% | −2.5% | +18.1% | +26.9% | −13.5% | +9.2% | +19.3% | −26.8% | +17.0% | +35.8% | −24.7% | +51.9% | +31.4% |
| BDX Becton, Dickinson and Company | 10 of 24 | −12.5% | −5.3% | −2.7% | +5.1% | +1.9% | −6.8% | +22.2% | +6.6% | +31.2% | +9.2% | +12.6% | +28.3% | +44.3% | +7.3% | −9.7% | +9.4% | +17.6% | −16.9% | +20.7% | +18.3% | +7.2% | +39.8% | +35.6% | −6.4% | — | — | — | — | — |
| CNMD CONMED Corporation | 10 of 29 | −40.0% | −36.8% | +24.5% | −37.0% | +27.4% | +1.2% | +75.7% | +27.4% | +17.3% | +2.2% | −0.4% | +7.8% | +55.0% | +11.2% | −2.9% | +15.9% | −4.8% | +3.6% | −0.1% | −2.3% | −16.7% | +19.4% | +21.5% | −1.9% | +162% | +32.4% | −21.6% | +25.8% | +28.0% |
| ZBH Zimmer Biomet Holdings, Inc. | 9 of 24 | −14.0% | −12.5% | −3.8% | +4.3% | −17.0% | +3.8% | +45.4% | −13.3% | +17.9% | +1.5% | −8.8% | +22.8% | +41.2% | +26.2% | −0.5% | −9.2% | +46.3% | −38.9% | −15.6% | +16.2% | −15.8% | +13.8% | +69.6% | +35.9% | — | — | — | — | — |
| GEHC GE HealthCare Technologies Inc. | 2 of 3 | +5.1% | +1.3% | +32.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| INSP Inspire Medical Systems, Inc. | 4 of 7 | −50.2% | −8.9% | −19.2% | +9.5% | +22.3% | +153% | +75.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ATEC Alphatec Holdings, Inc. | 5 of 19 | +129% | −39.3% | +22.4% | +8.1% | −21.3% | +105% | +210% | −13.9% | −17.1% | −10.8% | −78.7% | −29.8% | +21.8% | −4.1% | −36.3% | −49.4% | +127% | −53.4% | +35.1% | — | — | — | — | — | — | — | — | — | — |
| BSX Boston Scientific Corporation | 12 of 29 | +6.8% | +54.5% | +24.9% | +8.9% | +18.2% | −20.5% | +28.0% | +42.6% | +14.6% | +17.3% | +39.2% | +10.2% | +110% | +7.3% | −29.5% | −15.9% | +16.3% | −33.5% | −32.3% | −29.8% | −31.1% | −3.3% | +72.9% | +76.3% | +76.3% | −37.5% | −18.4% | +16.9% | −23.5% |
| ENOV Enovis Corporation | 7 of 17 | −39.3% | −21.7% | +4.7% | −32.4% | +20.2% | +5.1% | +74.1% | −47.3% | +10.3% | +53.9% | −54.7% | −19.0% | +57.8% | +41.7% | +54.7% | +52.9% | +15.9% | — | — | — | — | — | — | — | — | — | — | — | — |
| OFIX Orthofix Medical Inc. | 11 of 29 | −13.2% | +29.5% | −34.3% | −34.0% | −27.7% | −6.9% | −12.0% | −4.0% | +51.2% | −7.7% | +30.4% | +31.7% | −42.0% | +11.6% | +21.5% | −6.2% | +102% | −73.6% | +15.9% | +25.4% | +2.1% | −20.2% | +74.1% | −24.1% | +93.9% | +33.7% | +2.2% | +19.1% | +42.4% |
Risk and diversification
How SYK has fallen, how it held up in crashes beside the S&P 500 and its popular alternatives, and what moves independently of it.
What were SYK's worst declines?
A drawdown is the decline from a peak to the lowest point before a new high. This section presents SYK's five deepest drawdowns since it began trading in 1986, alongside the S&P 500's return over the same dates, and how long each took to recover. Together, these figures show how much an investor could have lost and how long it took to get back to even.
- In all three of SYK's worst declines, the S&P 500 held up better over the same dates.
- The slowest recovery came after SYK fell 58.6% from December 2007 to March 2009; it did not regain that peak until September 2013, four years later.
Green means SYK fell less than the S&P 500 over the same dates. Based on daily closing prices with dividends reinvested.
| During | SYK fell | S&P 500, same dates | Peak | Low | Time to the low | Back at the peak | Time to recover |
|---|---|---|---|---|---|---|---|
| 2008 financial crisis | −58.6% | −53.4% | Dec 2007 | Mar 2009 | 15 months | Sep 2013 | 4.5 years |
| No named crash | −57.0% | — | Dec 1991 | Jun 1993 | 18 months | Nov 1995 | 2.4 years |
| No named crash | −55.2% | — | Jul 1987 | Dec 1987 | 5 months | May 1989 | 17 months |
| Covid crash | −43.8% | −33.7% | Feb 2020 | Mar 2020 | 1 month | Oct 2020 | 7 months |
| No named crash | −36.0% | −6.9% | Jan 2000 | Mar 2000 | 2 months | Jun 2000 | 3 months |
How did SYK do in stock market crashes?
This section measures how far SYK, the S&P 500 and each alternative fell from peak to trough during every major market crash since 2000. A smaller decline means an investment held up better, and comparing results across crashes shows whether that resilience was consistent or a one-off.
- SYK fell further than the S&P 500 in seven of the ten crashes it has traded through. The clearest case was the Covid crash, when SYK fell 43.8% and the S&P 500 fell 33.7%.
- Among its popular alternatives, JNJ held up best, falling less than SYK in eight of the ten crashes they both traded through.
Newest crash first. Each figure is the fund's deepest fall within the crash window; green means a smaller fall than SYK.
| Investment | Held up better | 2023 regional bank crisisMar 2023 | 2022 bear marketJan 2022 | Covid crashFeb 2020 | Late-2018 sell-offSep 2018 | February 2018 volatility shockFeb 2018 | 2015 China and oil sell-offAug 2015 | 2011 euro debt crisisJul 2011 | 2010 flash crashMay 2010 | 2008 financial crisisOct 2007 | Dot-com bustMar 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYK This pageStryker Corporation | — | −1.4% | −31.4% | −43.8% | −18.8% | −8.8% | −15.6% | −23.0% | −3.8% | −58.6% | −26.9% |
| SPY S&P 500State Street SPDR S&P 500 ETF | 7 of 10 | −3.4% | −24.5% | −33.7% | −19.3% | −6.5% | −12.8% | −17.9% | −1.5% | −55.2% | −47.5% |
| CAH Cardinal Health, Inc. | 6 of 10 | −3.5% | −21.0% | −32.1% | −25.5% | −4.6% | −15.9% | −17.5% | −1.8% | −57.9% | −36.1% |
| THC Tenet Healthcare Corporation | 2 of 10 | −10.6% | −45.6% | −67.8% | −42.5% | −3.8% | −57.4% | −42.6% | −4.7% | −86.6% | −20.4% |
| ITGR Integer Holdings Corporation | 2 of 9 | −5.1% | −41.5% | −52.3% | −21.0% | −12.3% | −46.0% | −29.4% | 0.0% | −41.1% | — |
| HCA HCA Healthcare, Inc. | 1 of 7 | −2.2% | −39.5% | −54.4% | −20.6% | −3.8% | −31.3% | −49.0% | — | — | — |
| ISRG Intuitive Surgical, Inc. | 3 of 9 | −2.7% | −47.6% | −40.5% | −24.3% | −8.4% | −14.7% | −20.6% | −3.8% | −75.9% | — |
| JNJ Johnson & Johnson | 8 of 10 | −1.1% | −12.7% | −25.4% | −16.9% | −8.2% | −9.0% | −9.8% | −0.1% | −34.4% | −35.9% |
| GMED Globus Medical, Inc. | 2 of 6 | −5.9% | −34.8% | −38.0% | −28.0% | −5.1% | −23.6% | — | — | — | — |
| STE STERIS plc | 5 of 10 | −2.8% | −36.2% | −35.8% | −17.3% | −7.1% | −19.6% | −23.9% | −2.8% | −49.6% | −35.9% |
| EW Edwards Lifesciences Corporation | 6 of 9 | −3.8% | −36.0% | −33.2% | −20.0% | −6.1% | −9.7% | −19.4% | −2.4% | −31.9% | — |
| MDT Medtronic Plc | 7 of 10 | −2.1% | −27.9% | −36.0% | −13.8% | −7.2% | −17.6% | −18.0% | −1.5% | −56.5% | −44.2% |
| SNN Smith & Nephew plc | 5 of 10 | −0.4% | −38.8% | −46.2% | −12.7% | −4.8% | −18.6% | −21.8% | −3.9% | −55.2% | −26.7% |
| ABT Abbott Laboratories | 6 of 10 | −2.5% | −27.9% | −29.7% | −11.7% | −8.8% | −27.4% | −11.5% | −0.5% | −22.3% | −45.7% |
| BDX Becton, Dickinson and Company | 6 of 9 | −2.0% | −19.7% | −21.8% | −20.4% | −10.8% | −15.1% | −18.3% | −1.6% | −34.1% | — |
| CNMD CONMED Corporation | 1 of 10 | −6.1% | −50.9% | −62.1% | −28.1% | −6.3% | −35.9% | −26.0% | −3.9% | −64.6% | −42.2% |
| ZBH Zimmer Biomet Holdings, Inc. | 6 of 9 | 0.0% | −23.9% | −49.6% | −26.0% | −8.2% | −14.8% | −20.3% | −2.1% | −62.0% | — |
| GEHC GE HealthCare Technologies Inc. | 0 of 1 | −2.2% | — | — | — | — | — | — | — | — | — |
| INSP Inspire Medical Systems, Inc. | 0 of 4 | −9.6% | −44.7% | −53.7% | −29.5% | — | — | — | — | — | — |
| ATEC Alphatec Holdings, Inc. | 1 of 9 | −10.1% | −51.4% | −66.8% | −36.0% | −1.3% | −72.9% | −41.4% | −3.4% | −82.1% | — |
| BSX Boston Scientific Corporation | 4 of 10 | −1.2% | −25.2% | −40.0% | −18.7% | −8.0% | −15.2% | −24.0% | −3.2% | −63.5% | −56.7% |
| ENOV Enovis Corporation | 1 of 8 | −5.1% | −44.5% | −62.4% | −47.4% | −17.3% | −53.6% | −31.8% | −0.2% | — | — |
| OFIX Orthofix Medical Inc. | 1 of 10 | −8.7% | −60.0% | −50.6% | −21.8% | −9.5% | −19.6% | −26.7% | −2.6% | −85.1% | −40.8% |
How closely does SYK move with the S&P 500?
Upside capture measures how much of the S&P 500's gains an investment kept in the months the market rose, and downside capture how much of its losses it took in the months the market fell. An investment that captures more of the gains than the losses has compounded ahead of the market over time. This section compares SYK with its popular alternatives on both measures, and on beta (how strongly each has moved with the market), over the past 10 years.
- CAH took just 51% of the S&P 500's losses, against 96% for SYK, while still keeping 71% of its gains.
- Over the past 10 years, SYK captured 82% of the S&P 500's gains in rising months and 96% of its losses in falling months, with a beta of 0.88. Its share of the market's losses was larger than its share of the gains.
- Eight of the 19 popular alternatives had a higher capture ratio (upside capture divided by downside capture) than SYK's 0.86, led by CAH, JNJ and ITGR.
Monthly total returns over the past 10 years, measured against SPY. 100% capture or a beta of 1.00 means moving in line with the S&P 500. Green marks a better figure than SYK's: more upside, less downside or a higher capture ratio. Sorted by capture ratio.
| Investment | Upside capture | Downside capture | Capture ratio | Beta |
|---|---|---|---|---|
| SYK This pageStryker Corporation | 82% | 96% | 0.86 | 0.88 |
| CAH Cardinal Health, Inc. | 71% | 51% | 1.40 | 0.75 |
| JNJ Johnson & Johnson | 64% | 53% | 1.20 | 0.46 |
| ITGR Integer Holdings Corporation | 118% | 111% | 1.06 | 1.00 |
| THC Tenet Healthcare Corporation | 173% | 168% | 1.03 | 1.87 |
| HCA HCA Healthcare, Inc. | 135% | 140% | 0.97 | 1.37 |
| ABT Abbott Laboratories | 76% | 79% | 0.96 | 0.64 |
| STE STERIS plc | 89% | 97% | 0.92 | 0.76 |
| ISRG Intuitive Surgical, Inc. | 136% | 154% | 0.88 | 1.28 |
| GMED Globus Medical, Inc. | 118% | 148% | 0.80 | 1.03 |
| EW Edwards Lifesciences Corporation | 88% | 120% | 0.73 | 0.97 |
| BSX Boston Scientific Corporation | 76% | 109% | 0.70 | 0.72 |
| BDX Becton, Dickinson and Company | 53% | 77% | 0.69 | 0.48 |
| MDT Medtronic Plc | 62% | 105% | 0.59 | 0.68 |
| CNMD CONMED Corporation | 90% | 159% | 0.57 | 1.25 |
| ATEC Alphatec Holdings, Inc. | 63% | 117% | 0.54 | 1.28 |
| SNN Smith & Nephew plc | 50% | 98% | 0.52 | 0.63 |
| ZBH Zimmer Biomet Holdings, Inc. | 62% | 139% | 0.44 | 0.88 |
| ENOV Enovis Corporation | 95% | 252% | 0.38 | 1.65 |
| OFIX Orthofix Medical Inc. | 41% | 180% | 0.23 | 0.88 |
What diversifies SYK?
Correlation measures how closely two investments move together, on a scale from 1 (in lockstep) through 0 (unrelated) to -1 (in opposite directions). This section lists large ETFs and stocks whose returns have had a low correlation with SYK's. Because such investments tend not to fall at the same time, pairing SYK with them can reduce a portfolio's overall swings.
- Moving a fifth of the money in SYK into GLD would have cut the portfolio's volatility by 15% over the past 5 years and raised its annual return (+1.9% for SYK alone, +5.6% for the mix).
- GLD made money in four of the five calendar years in which SYK lost money.
- Among large ETFs, DXJ, SMH and GLD have moved largely independently of SYK over the past 5 years, with correlations of 0.43 or lower, and each still earned a positive 5-year return.
Only ETFs with at least $1.0B in assets and stocks worth at least $10B, with a correlation below 0.5 over the past 5 years and a positive return, are included, ranked by Sharpe ratio; funds that hold the same thing are shown once. The year columns are the years in which SYK lost money. The last two columns show a portfolio that is 80% SYK and 20% the other investment, rebalanced monthly.
ETFs
| Investment | Correlation | 5Y return | Sharpe | 2025 | 2022 | 2011 | 2008 | 2005 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|---|---|
| SYK Stryker Corporation (this page) | 1.00 | +17.2% | 0.25 | −1.5% | −7.4% | −6.1% | −46.0% | −7.7% | 23.4% | +1.9% |
| DXJ InternationalWisdomTree Japan Hedged Equity Fund | 0.43 | +225% | 1.34 | +32.8% | +6.0% | −16.1% | −20.8% | — | 20.0% | +6.9% |
| SMH TechnologyVanEck Semiconductor ETF | 0.17 | +323% | 0.97 | +49.2% | −33.5% | +6.8% | −44.7% | +10.8% | 21.0% | +9.5% |
| GLD CommoditiesSPDR Gold Shares | 0.24 | +126% | 0.96 | +63.7% | −0.8% | +9.6% | +4.9% | +17.8% | 19.8% | +5.6% |
| IOO InternationaliShares Global 100 ETF | 0.45 | +107% | 0.94 | +27.0% | −16.3% | −4.1% | −36.1% | +4.3% | 20.3% | +5.1% |
| SPMO Broad MarketInvesco S&P 500 Momentum ETF | 0.44 | +136% | 0.93 | +26.6% | −10.4% | — | — | — | 20.9% | +6.1% |
| XLE EnergyState Street Energy Select Sector SPDR ETF | 0.32 | +177% | 0.93 | +7.9% | +64.4% | +2.8% | −39.0% | +40.1% | 21.0% | +6.6% |
| VLUE Broad MarketiShares MSCI USA Value Factor ETF | 0.39 | +109% | 0.90 | +32.7% | −14.2% | — | — | — | 20.6% | +5.4% |
| EWT TechnologyiShares MSCI Taiwan ETF | 0.12 | +153% | 0.89 | +28.4% | −28.9% | −21.8% | −45.3% | +4.7% | 20.0% | +6.5% |
Stocks
| Investment | Correlation | 5Y return | Sharpe | 2025 | 2022 | 2011 | 2008 | 2005 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|---|---|
| SYK Stryker Corporation (this page) | 1.00 | +17.2% | 0.25 | −1.5% | −7.4% | −6.1% | −46.0% | −7.7% | 23.4% | +1.9% |
| CLS Hardware, Equipment & PartsCelestica Inc. | 0.09 | +3,143% | 1.47 | +220% | +1.3% | −24.4% | −20.5% | −25.2% | 23.0% | +21.3% |
| FIX Engineering & ConstructionComfort Systems USA, Inc. | 0.33 | +1,636% | 1.46 | +121% | +17.0% | −17.0% | −15.2% | +20.1% | 23.2% | +17.1% |
| MCK Medical - DistributionMcKesson Corporation | 0.41 | +413% | 1.44 | +44.5% | +51.8% | +11.8% | −40.4% | +64.9% | 21.3% | +8.4% |
| MPC Oil & Gas Refining & MarketingMarathon Petroleum Corporation | 0.26 | +690% | 1.41 | +19.2% | +86.6% | — | — | — | 21.3% | +11.0% |
| ATI Manufacturing - Metal FabricationATI Inc. | 0.33 | +1,008% | 1.34 | +109% | +87.5% | −12.2% | −70.0% | +68.2% | 23.6% | +13.7% |
Common questions
What was SYK's worst drawdown?
SYK's deepest decline since it began trading in 1986 was 58.6%, from December 2007 to March 2009. It took about four years from the low to climb back to its old high.
What were SYK's best and worst years?
Over 29 full calendar years, SYK's best year was 1998, when it returned 47.9%. Its worst was 2008, with a return of -46.0%.
Is there a better investment than SYK?
Among SYK's popular alternatives, JNJ earned more than SYK with less volatility over the past 5 years: 12.7% a year at 17.9% volatility, against 3.2% a year at 25.7%. Looking beyond its popular alternatives, NVS (pharmaceuticals) and COR (health care distribution) earned more than SYK with less volatility over the past 5 years. NVS returned 17.1% a year at 20.7% volatility, against 3.2% a year at 25.7%.
Is SYK more volatile than the S&P 500?
Yes. SYK's volatility over the past 5 years was 25.7%, 1.5 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, SYK's return lands within 25.7% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump.
What is SYK's Sharpe ratio?
SYK's Sharpe ratio over the past 5 years was 0.25, against 0.79 for the S&P 500, so SYK earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings.
How correlated is SYK with the S&P 500?
Over the past 5 years, SYK's monthly returns had a correlation of 0.52 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They often move together: some diversification next to an index fund, but not a cushion. In the table, the correlation column measures each option against SYK instead: the lower it is, the more that option would diversify a SYK holding.
What are the best alternatives to SYK?
Of the 21 popular alternatives we compared, seven outperformed SYK in at least 3 of 5 short-term and 2 of 3 long-term timeframes, with dividends reinvested: CAH, THC and ITGR.
Did SYK outperform the S&P 500?
SYK finished ahead of the S&P 500 (SPY) in 15 of 29 full calendar years. In 2025, it returned -1.5%, against +17.7% for the index.
How did SYK do in stock market crashes?
SYK fell less than the S&P 500 (SPY) in two of the ten major crashes it has traded through, and further in seven. The clearest case was the Covid crash, when SYK fell 43.8% and the S&P 500 fell 33.7%.
What diversifies SYK?
These had a low correlation with SYK over the past 5 years and still earned a positive 5-year return: among large ETFs, DXJ (correlation 0.43), SMH (correlation 0.17) and GLD (correlation 0.24); among large stocks, CLS (correlation 0.09), FIX (correlation 0.33) and MCK (correlation 0.41). A correlation near zero means the two have moved largely independently.
How we measure
- Short-term periods are 1M, 3M, 6M, YTD, 1Y; long-term periods are 3Y, 5Y, 10Y. An investment outperformed in a period when its total return, with dividends reinvested, was higher than SYK's. Returns within 0.5 points or 3% of SYK's, whichever is larger, count as a tie.
- "Qualified" means outperforming in at least 3 of 5 short-term periods and 2 of 3 long-term periods. "All-weather" means outperforming in every long-term period and all but one short-term period.
- Popular alternatives are the funds and stocks most often compared with this one. We include only those that trade today, are not leveraged or inverse, and hold at least $200 million.
- Volatility is the annualized standard deviation of daily returns over 5 years, a measure of how much the price typically swings in a year. The Sharpe ratio is the return above cash for each unit of that volatility.
- A decline, or drawdown, runs from a peak to the lowest close before the next high. The worst decline ever uses all the price history we have; comparisons between funds use the past 10 years so that younger funds are judged on the same stretch.
- Sector overlap is the share of assets two funds hold in the same sectors. Correlation and the mixed-portfolio figures use monthly returns.
- Upside and downside capture follow Morningstar's definition: the compound monthly return in the months the S&P 500 rose (or fell), divided by the S&P 500's compound return in those months. Beta measures how strongly monthly returns have moved with the S&P 500. All three use the same window for every investment.
- Figures are computed from daily adjusted prices and update after each trading day. Past performance does not predict future results.
More research
Popular alternatives to SYK
CAHCardinal Health
HCAHCA Healthcare
ISRGIntuitive Surgical
JNJJohnson & Johnson
EWEdwards Lifesciences
MDTMedtronic
ABTAbbott Laboratories
BDXBecton, Dickinson and Company
BSXBoston Scientific